SS18 and rhabdomyosarcoma: Pathognomonic fusions were also identified, such as PAX3-FOXO1 and PAX7-FOXO1 in alveolar rhabdomyosarcoma, SS18-SSX in synovial sarcoma, and NAB2-STAT6 in solitary fibrous tumors.